BUSINESSBLOOMBERG
Drugmaker Apotex Files for Canada IPO Showing Revenue Jump
Drugmaker Apotex has filed for an initial public offering (IPO) in Canada, accompanied by a reported revenue increase. The company's Toronto-based facility is highlighted in the article.
Related Signal
Adjacent reporting
- Flurry of US IPOs Race to Tap Market Ahead of SpaceX Debut
- SpaceX Files for IPO on Nasdaq Under SPCX Symbol
- Starboard Builds Stake in Flowserve, Push for Changes
- Applied Aerospace Files for IPO, Joining Pre-SpaceX Rush
- What’s Next for Manycore After Blockbuster HK Debut
- Blackstone Files for IPO of Data Center Acquisition Firm